1. Home
  2. GFAI vs CING Comparison

GFAI vs CING Comparison

Compare GFAI & CING Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • GFAI
  • CING
  • Stock Information
  • Founded
  • GFAI 2018
  • CING 2012
  • Country
  • GFAI Singapore
  • CING United States
  • Employees
  • GFAI N/A
  • CING N/A
  • Industry
  • GFAI Diversified Commercial Services
  • CING Biotechnology: Pharmaceutical Preparations
  • Sector
  • GFAI Consumer Discretionary
  • CING Health Care
  • Exchange
  • GFAI Nasdaq
  • CING Nasdaq
  • Market Cap
  • GFAI 23.5M
  • CING 22.0M
  • IPO Year
  • GFAI N/A
  • CING 2021
  • Fundamental
  • Price
  • GFAI $1.13
  • CING $3.70
  • Analyst Decision
  • GFAI Strong Buy
  • CING Strong Buy
  • Analyst Count
  • GFAI 1
  • CING 4
  • Target Price
  • GFAI $4.50
  • CING $31.00
  • AVG Volume (30 Days)
  • GFAI 517.0K
  • CING 132.0K
  • Earning Date
  • GFAI 09-25-2025
  • CING 11-06-2025
  • Dividend Yield
  • GFAI N/A
  • CING N/A
  • EPS Growth
  • GFAI N/A
  • CING N/A
  • EPS
  • GFAI N/A
  • CING N/A
  • Revenue
  • GFAI $36,347,373.00
  • CING N/A
  • Revenue This Year
  • GFAI $5.66
  • CING N/A
  • Revenue Next Year
  • GFAI $4.69
  • CING N/A
  • P/E Ratio
  • GFAI N/A
  • CING N/A
  • Revenue Growth
  • GFAI 0.18
  • CING N/A
  • 52 Week Low
  • GFAI $0.76
  • CING $3.02
  • 52 Week High
  • GFAI $3.88
  • CING $6.01
  • Technical
  • Relative Strength Index (RSI)
  • GFAI 48.74
  • CING 39.94
  • Support Level
  • GFAI $1.04
  • CING $3.70
  • Resistance Level
  • GFAI $1.11
  • CING $4.00
  • Average True Range (ATR)
  • GFAI 0.06
  • CING 0.23
  • MACD
  • GFAI 0.01
  • CING 0.02
  • Stochastic Oscillator
  • GFAI 50.28
  • CING 15.27

About GFAI Guardforce AI Co. Limited

Guardforce AI Co Ltd is an integrated solution provider, specializing in security solutions, and also focuses on implementing AI and robotics solutions to improve business operational efficiency and sales and marketing processes, especially for the retail and travel industry in the Asia Pacific. The company's operating business segments include Secured Logistics, AI & Robotics Solution Business, General Security Solutions, and Corporate and others. A majority of its revenue is generated from the Secured Logistics segment, which includes services like cash-in-transit, dedicated vehicles to banks, ATM management, cash center operations, cash processing, coin processing, cheque center, and cash deposit machine solutions.

About CING Cingulate Inc.

Cingulate Inc is a clinical-stage biopharmaceutical company utilizing its proprietary precision timed-release drug delivery platform to build and advance a pipeline of next-generation pharmaceutical products designed to improve the lives of patients suffering from frequently diagnosed conditions characterized by burdensome daily dosing regimens and suboptimal treatment outcomes. The company focuses on the treatment of Attention Deficit/Hyperactivity Disorder (ADHD) and anxiety, and identifying and evaluating additional therapeutic area to use PTR technology to develop future product candidates.

Share on Social Networks: